This study is in progress, not accepting new patients
A Phase 2 Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Concert Pharmaceuticals
- ID
- NCT04784533
- Phase
- Phase 2 Alopecia Research Study
- Study Type
- Interventional
- Participants
- Expecting 300 study participants
- Last Updated